ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,815.84
0.03%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Charles River Laboratories International Inc (CRL)

  7. Charles River Laboratories International Inc (CRL) Noticias

CRL

Charles River Laboratories (CRL)

Charles River Laboratories International Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:CRL
FechaHoraFuenteTítuloSímboloCompañía
10/05/202415:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
10/05/202410:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
09/05/202415:20Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:CRLCharles River Laboratories International Inc
09/05/202408:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CRLCharles River Laboratories International Inc
09/05/202406:00Business WireCharles River Laboratories Announces First-Quarter 2024 ResultsNYSE:CRLCharles River Laboratories International Inc
02/05/202407:00Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPNYSE:CRLCharles River Laboratories International Inc
22/04/202407:00Business WireCharles River Laboratories Achieves 100% Renewable Electricity Usage GloballyNYSE:CRLCharles River Laboratories International Inc
16/04/202407:00Business WireCharles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal TestingNYSE:CRLCharles River Laboratories International Inc
12/04/202407:00Business WireCharles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
11/04/202407:00Business WireCharles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic PathologyNYSE:CRLCharles River Laboratories International Inc
09/04/202407:00Business WireCharles River Announces Rare Disease Gene Therapy Collaboration with Axovia TherapeuticsNYSE:CRLCharles River Laboratories International Inc
04/04/202407:00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
01/04/202407:00Business WireCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024NYSE:CRLCharles River Laboratories International Inc
27/03/202407:00Business WireCharles River Laboratories Publishes 2023 Corporate Citizenship ReportNYSE:CRLCharles River Laboratories International Inc
21/03/202407:00Business WireCharles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of MedicineNYSE:CRLCharles River Laboratories International Inc
14/03/202407:00Business WireCharles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing CollaborationNYSE:CRLCharles River Laboratories International Inc
12/03/202407:00Business WireCharles River Laboratories to Present at Barclays Global Healthcare ConferenceNYSE:CRLCharles River Laboratories International Inc
11/03/202415:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
29/02/202401:00PR Newswire (US)Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human UseNYSE:CRLCharles River Laboratories International Inc
21/02/202407:00Business WireCharles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to ManufacturingNYSE:CRLCharles River Laboratories International Inc
20/02/202407:08Business WireCharles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem CellsNYSE:CRLCharles River Laboratories International Inc
14/02/202406:00Business WireCharles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 GuidanceNYSE:CRLCharles River Laboratories International Inc
31/01/202416:34Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:CRLCharles River Laboratories International Inc
30/01/202415:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
29/01/202407:00Business WireCharles River Introduces the First Rapid Animal-Free Bacterial Endotoxin TestNYSE:CRLCharles River Laboratories International Inc
24/01/202415:30Business WireCharles River Laboratories Adds Reshema Kemps-Polanco to Board of DirectorsNYSE:CRLCharles River Laboratories International Inc
23/01/202415:30Business WireCharles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
16/01/202407:00Business WireCharles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector ManufacturingNYSE:CRLCharles River Laboratories International Inc
08/01/202407:00Business WireCharles River Laboratories to Present at J.P. Morgan Healthcare ConferenceNYSE:CRLCharles River Laboratories International Inc
18/12/202307:00Business WireCharles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing CollaborationNYSE:CRLCharles River Laboratories International Inc
 Showing the most relevant articles for your search:NYSE:CRL

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
FX
EURUSD
Euro vs US Dollar
NASDAQ
AAPL
Apple
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
FX
USDMXN
US Dollar vs MXN
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
JPM
JP Morgan Chase
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
KO
Coca Cola
NASDAQ
TSLA
Tesla
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados